Radiotherapy and Oncology· 2017Q1
Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen
- 427citations
- Q1SCImago
- 2017year
Short summary
A Phase I trial found stereotactic MR-guided online-adaptive radiotherapy (SMART) to be feasible and safe for abdominal malignancies, enabling dose escalation or improved organ-at-risk sparing in 81% of fractions.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Radiation
RadiationPhysics and Astronomy